The use of whole genome amplification in the study of human disease.
The availability of large amounts of genomic DNA is of critical importance for many of the molecular biology assays used in the analysis of human disease. However, since the amount of patient tissue available is often limited and as particular foci of interest may consist of only a few hundred cells, the yield of DNA is often insufficient for extensive analysis. To address this problem, several whole genome amplification (WGA) methodologies have been developed. Initial WGA approaches were based on the polymerase chain reaction (PCR). However, recent reports have described the use of non-PCR-based linear amplification protocols for WGA. Using these methods, it is possible to generate microgram quantities of DNA starting with as little as 1mg of genomic DNA. This review will provide an overview of WGA approaches and summarize some of the uses for amplified DNA in various high-throughput genetic applications.
Hughes
Simon
S
Ontario Cancer Institute, Princess Margaret Hospital, University Health Network, Ontario, Canada. sih3@yahoo.com
Arneson
Nona
N
Done
Susan
S
Squire
Jeremy
J
D004259:DNA-Directed DNA Polymerase / Q000378:metabolism*; D015894:Genome, Human; D006801:Humans; D021141:Nucleic Acid Amplification Techniques / Q000379:methods*; D016133:Polymerase Chain Reaction / Q000379:methods*
C034970:bacteriophage T7 induced DNA polymerase; D004259:DNA-Directed DNA Polymerase